The present invention relates to the production of modified microscale and nanoscale particles that have enhanced in vivo delivery characteristics. The resultant particles can be used in any of a number of applications including informatics, detection, diagnosis, imaging, and/or therapeutics. Further, the modified particles of the present invention have enhanced circulation half time and elimination rate constant characteristics, and enhanced biodistribution.
